Prevalence of dermatological toxicities in patients with melanoma undergoing immunotherapy: Systematic review and meta-analysis.
Náthali Felícia Mineiro Dos Santos GarrettAna Cristina Carvalho da CostaElaine Barros FerreiraGiovanni DamianiPaula Elaine Diniz Dos ReisChristiane Inocêncio VasquesPublished in: PloS one (2021)
The most prevalent side effects in patients treated with checkpoint inhibitors are pruritus, rash, and vitiligo, and they are rated mostly as grades 1 and 2 adverse events. Remarkably, vitiligo is most commonly found in patients treated with PD-1 inhibitors.
Keyphrases